Back |
home / stock / ino / ino message board
Subject | By | Source | When |
---|---|---|---|
I'd suggest peeling this announcement back. Advaccine has | Opus X | investorshub | 01/05/2023 6:53:37 PM |
Looks like Advaccine has been approved to be | Opus X | investorshub | 01/05/2023 6:12:16 PM |
What does this have to do with $INO? | MiamiGent | investorshub | 12/31/2022 2:44:51 AM |
Nonlinear memory cell is an arbitrary geometric form, | doc2016 | investorshub | 12/30/2022 7:36:00 PM |
Class switch towards non-inflammatory, spike-specific IgG4 antibodies after | doc2016 | investorshub | 12/30/2022 5:45:16 PM |
sorry , wrong board. | doc2016 | investorshub | 12/15/2022 10:24:32 PM |
I hardly understood a thing too. | MiamiGent | investorshub | 12/14/2022 3:15:31 AM |
doc, WTF nothing makes sense | smoking guns | investorshub | 12/12/2022 7:08:04 PM |
lol. call control is ? puddle /ploinks......except vcsy | doc2016 | investorshub | 12/10/2022 7:29:24 PM |
china is now all about business and economy | doc2016 | investorshub | 12/10/2022 2:02:59 PM |
Wowzer - Talk about a premonition: Avoid Inovio | gew59 | investorshub | 12/10/2022 2:07:25 AM |
Well I saw the lawsuit and looked up | retired early | investorshub | 12/05/2022 4:40:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
Stephens initiated coverage on INOVIO Pharmaceuticals Inc (NASDAQ:INO), noting the company’s diversified clinical pipeline of ...
2024-05-13 21:45:14 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q1 2024 Earnings Call May 13, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call ...
2024-05-13 18:00:04 ET Sudan Loganathan from Stephens issued a price target of $20.00 for INO on 2024-05-13 16:32:00. The adjusted price target was set to $20.00. At the time of the announcement, INO was trading at $11.36. The overall price target consensus is at $4.00 w...